Cost of care and antibiotic prescribing attitudes for community-acquired complicated intra-abdominal infections in Italy: A retrospective study

World Journal of Emergency Surgery

Volumn 9, Issue 1, 2014, Pages

  Dalfino, Lidia ^a   Bruno, Francesco ^a   Colizza, Sergio ^b   Concia, Ercole ^c   Novelli, Andrea ^d   Rebecchi, Fabrizio ^e   Spandonaro, Federico ^f   Alato, Cristina ^f  

^a UNIVERSITY OF BARI   (Italy)

^b Department of General Surgery Fatebenefratelli Isola Tiberina ^*  (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Antibiotics; Community acquired intra abdominal infections; Cost of care; Direct costs; Hospitalization

Indexed keywords

EID: 84902740965     PISSN: None     EISSN: 17497922     Source Type: Journal    
DOI: 10.1186/1749-7922-9-39     Document Type: Article

References (14)

1. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O'Neill PJ, Chow AW, Dellinger EP, Eachempati SR, Gorbach S, Hilfiker M, May AK, Nathens AB, Sawyer RG, Bartlett JG. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010, 50:133-164.
2. Cattan P, Yin DD, Sarfati E, Lyu R, De Zelicourt M, Fagnani F. Cost of care for inpatients with community-acquired intra-abdominal infections. Eur J Clin Microbiol Infect Dis 2002, 21:787-793.
3. Krobot K, Yin D, Zhang Q, Sen S, Altendorf-Hofmann A, Scheele J, Sendt W. Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis 2004, 23:682-687.
4. Tellado JM, Sen SS, Caloto MT, Kumar RN, Nocea G. Consequences of inappropriate initial empiric parenteral antibiotic therapy among patients with community-acquired intra-abdominal infections in Spain. Scand J Infect Dis 2007, 39:947-955.
5. Wong PF, Gilliam AD, Kumar S, Shenfine J, O'Dair GN, Leaper DJ. Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults. Cochrane Database Sys Rev 2005, 18:CD004539.
6. Sturkenboom MC, Goettsch WG, Picelli G, In't Veld B, Yin DD, De Jong RB, Go PM, Herings RM. Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs. Br J Clin Pharmacol 2005, 60:438-443.
7. Edelsberg J, Berger A, Schell S, Mallick R, Kuznik A, Oster G. Economic consequences of failure of initial antibiotic therapy in hospitalized adults with complicated intra-abdominal infections. Surg Infect 2008, 9:335-347.
8. Sartelli M, Catena F, Ansaloni L, Leppaniemi A, Taviloglu K, van Goor H, Viale P, Lazzareschi DV, Coccolini F, Corbella D, de Werra C, Marrelli D, Colizza S, Scibè R, Alis H, Torer N, Navarro S, Sakakushev B, Massalou D, Augustin G, Catani M, Kauhanen S, Pletinckx P, Kenig J, Di Saverio S, Jovine E, Guercioni G, Skrovina M, Diaz-Nieto R, Ferrero A, et al. Complicated intra-abdominal infections in Europe: a comprehensive review of the CIAO study. World J Emerg Surg 2012, 7:36.
9. Sartelli M, Viale P, Catena F, Ansaloni L, Moore E, Malangoni M, Moore FA, Velmahos G, Coimbra R, Ivatury R, Peitzman A, Koike K, Leppaniemi A, Biffl W, Burlew CC, Balogh ZJ, Boffard K, Bendinelli C, Gupta S, Kluger Y, Agresta F, Di Saverio S, Wani I, Escalona A, Ordonez C, Fraga GP, Junior GA, Bala M, Cui Y, Marwah S, et al. 2013 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg 2013, 8:3.
10. Wilson SE, Turpin RS, Hu XH, Sullivan E, Mansley EC, Ma L. Does initial choice of antimicrobial therapy affect length of stay for patients with complicated intra-abdominal infections?. Am Surg 2005, 71:816-820.
11. De Lalla F, Eandi M. Indagine sull'uso di antibiotici nel trattamento delle infezioni delle basse vie respiratorie negli ospedali italiani: considerazioni farmacoeconomiche. G Ital Chemioter 1998, 45:59-87.
12. Agenzia Italiana del Farmaco (AIFA) Italian Pharmaceutical Formulary. 2009, http://www.agenziafarmaco.gov.it/wscs_render_attachment_by_id/111.84470.1172743348645ce4c.pdf?id=111.81951.1172658490314 [accessed 26/02/2011], Agenzia Italiana del Farmaco (AIFA).
13. Hawser SP, Bouchillon SK, Hoban DJ, Badal RE. In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli from patients with intra-abdominal infections worldwide from 2005-2007: results from the SMART study. Int J Antimicrob Agents 2009, 34:585-588.
14. Hawser SP, Bouchillon SK, Hoban DJ, Badal RE, Canton R, Baquero F. Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother 2010, 54:3043-3046.